Biohit strikes Dx supply deal with Hefei Medicine

05/17/2013 | GenomeWeb Daily News (free registration)

Biohit, a biotech company based in Finland, has tapped Hefei Medicine to distribute its diagnostic products in China for undisclosed terms. The deal covers products such as the GastroPanel system, a blood-based biomarker assay used to detect Helicobacter pylori.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA